Skip to main content
Erschienen in: Forensic Science, Medicine and Pathology 3/2018

12.05.2018 | Case Report

Fatal unexpected death due to familial hemophagocytic lymphohistiocytosis type 3

verfasst von: Jiao Mu, Chunting Jin, Zhenglian Chen, Jianfeng Li, Bin Lv, Hongmei Dong

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Familial hemophagocytic lymphohistiocytosis is a rare autosomal recessive disorder of immune dysregulation associated with uncontrolled activation of cytotoxic T cells and macrophages. Herein, we report a case of a 14-month-old Chinese boy who presented with fever, abdominal distension and thrombopenia, and died within 3 days of admission to the hospital. Postmortem examination revealed pleuroperitoneal fluid, enlarged mesenteric lymph nodes and hepatosplenomegaly. Histopathological examination showed interstitial pneumonia, hepatonecrosis and hemophagocytosis. Immunohistochemical staining of the spleen, lymph node and liver specimens revealed numerous cytotoxic T cells (CD8+) and histiocytes (CD68+). EBER1-positive cells were observed in lymphocytes of the spleen, lymph node, liver and lungs by in situ hybridization. UNC13D mutation was identified, although the boy had no family history. The following medico-legal autopsy case is being reported for its rarity in the forensic setting. We addresses the need for genetic testing in addition to a thorough clinical history, appropriate laboratory tests, histological examination and immunohistochemical analysis for the rapid and accurate diagnosis of familial hemophagocytic lymphohistiocytosis.
Literatur
1.
Zurück zum Zitat Serrão T, Dias A, Nunes P, Figueiredo A. An uncommon presentation of EBV-driven HLH. Primary or secondary? An ongoing dilemma. BMJ Case Rep 2015;2015. Serrão T, Dias A, Nunes P, Figueiredo A. An uncommon presentation of EBV-driven HLH. Primary or secondary? An ongoing dilemma. BMJ Case Rep 2015;2015.
2.
Zurück zum Zitat Liapis K, Apostolidis J, Delimpasis S. EBV-associated hemophagocytic syndrome. Am J Hematol. 2011;86:422.CrossRefPubMed Liapis K, Apostolidis J, Delimpasis S. EBV-associated hemophagocytic syndrome. Am J Hematol. 2011;86:422.CrossRefPubMed
3.
Zurück zum Zitat Antonodimitrakis P, Wassberg C, Gerovasileiou S, Back J, Hällgren R, Olsen B. Fulminant hemophagocytic lymphohistiocytosis secondary to a reactivated EBV infection: a case report. Ups J Med Sci. 2013;118:42–5.CrossRefPubMedPubMedCentral Antonodimitrakis P, Wassberg C, Gerovasileiou S, Back J, Hällgren R, Olsen B. Fulminant hemophagocytic lymphohistiocytosis secondary to a reactivated EBV infection: a case report. Ups J Med Sci. 2013;118:42–5.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Elstak E, Jong AD, Sluijs PVD. A platform for complementation and characterization of familial haemophagocytic lymphohistiocytosis 3 mutations. J Immunol Methods. 2011;365:58–66.CrossRefPubMed Elstak E, Jong AD, Sluijs PVD. A platform for complementation and characterization of familial haemophagocytic lymphohistiocytosis 3 mutations. J Immunol Methods. 2011;365:58–66.CrossRefPubMed
6.
Zurück zum Zitat Gholam C, Grigoriadou S, Gilmour KC, Gaspar HB. Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management. Clin Exp Immunol. 2011;163:271–83.CrossRefPubMedPubMedCentral Gholam C, Grigoriadou S, Gilmour KC, Gaspar HB. Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management. Clin Exp Immunol. 2011;163:271–83.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Bell MD, Wright RK. Fatal virus-associated hemophagocytic syndrome in a young adult producing nontraumatic splenic rupture. J Forensic Sci. 1992;37:1407–17.PubMed Bell MD, Wright RK. Fatal virus-associated hemophagocytic syndrome in a young adult producing nontraumatic splenic rupture. J Forensic Sci. 1992;37:1407–17.PubMed
8.
Zurück zum Zitat Chute DJ, Rawley J, Cox J, Bready RJ. Sudden unexpected death due to hemophagocytic lymphohistiocytosis syndrome. J Forensic Sci. 2013;58(4):1080.CrossRefPubMed Chute DJ, Rawley J, Cox J, Bready RJ. Sudden unexpected death due to hemophagocytic lymphohistiocytosis syndrome. J Forensic Sci. 2013;58(4):1080.CrossRefPubMed
9.
Zurück zum Zitat Ondruschka B, Habeck JO, Hädrich C, Dreßler J, Bayer R. Rare cause of natural death in forensic setting: hemophagocytic syndrome. Int J Legal Med. 2016;130:777–81.CrossRefPubMed Ondruschka B, Habeck JO, Hädrich C, Dreßler J, Bayer R. Rare cause of natural death in forensic setting: hemophagocytic syndrome. Int J Legal Med. 2016;130:777–81.CrossRefPubMed
10.
Zurück zum Zitat Zhang JR, Liang XL, Jin R, Lu G. HLH-2004 protocol: diagnostic and therapeutic guidelines for childhood hemophagocytic lymphohistiocytosis. Chin J Contemp Pediatr. 2013;15:686. Zhang JR, Liang XL, Jin R, Lu G. HLH-2004 protocol: diagnostic and therapeutic guidelines for childhood hemophagocytic lymphohistiocytosis. Chin J Contemp Pediatr. 2013;15:686.
11.
Zurück zum Zitat Ishii E, Ueda I, Shirakawa R, Yamamoto K, Horiuchi H, Ohga S, et al. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood. 2005;105:3442.CrossRefPubMed Ishii E, Ueda I, Shirakawa R, Yamamoto K, Horiuchi H, Ohga S, et al. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood. 2005;105:3442.CrossRefPubMed
12.
Zurück zum Zitat Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461.CrossRefPubMed Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461.CrossRefPubMed
13.
Zurück zum Zitat Santoro A, Cannella S, Bossi G, Gallo F, Trizzino A, Pende D, et al. Novel Munc13–4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis. J Med Genet. 2006;43:953–60.CrossRefPubMedPubMedCentral Santoro A, Cannella S, Bossi G, Gallo F, Trizzino A, Pende D, et al. Novel Munc13–4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis. J Med Genet. 2006;43:953–60.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Lewkowicz E, Darnige L, Auffret N, Damotte D, Andrieu JM, Jenabian A. Atypical skin lesions revealing an EBV-associated hemophagocytic syndrome after a large B cell lymphoma in complete remission. Leuk Lymphoma. 2007;48:421.CrossRefPubMed Lewkowicz E, Darnige L, Auffret N, Damotte D, Andrieu JM, Jenabian A. Atypical skin lesions revealing an EBV-associated hemophagocytic syndrome after a large B cell lymphoma in complete remission. Leuk Lymphoma. 2007;48:421.CrossRefPubMed
15.
Zurück zum Zitat Janka G, Stadt UZ. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2007;166:233–46. Janka G, Stadt UZ. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2007;166:233–46.
Metadaten
Titel
Fatal unexpected death due to familial hemophagocytic lymphohistiocytosis type 3
verfasst von
Jiao Mu
Chunting Jin
Zhenglian Chen
Jianfeng Li
Bin Lv
Hongmei Dong
Publikationsdatum
12.05.2018
Verlag
Springer US
Erschienen in
Forensic Science, Medicine and Pathology / Ausgabe 3/2018
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-018-9986-6

Weitere Artikel der Ausgabe 3/2018

Forensic Science, Medicine and Pathology 3/2018 Zur Ausgabe

Original Article

Single stab injuries

Commentary

Death by food

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie